Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 févr. 2026 03h30 HE | Source: FundaMental Pharma GmbH

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

FundaMental Pharma chosen among twelve companies to showcase its groundbreaking TRD candidate, FMP374, at the Bio-Neuroscience Conference.
20 mars 2024 02h00 HE | Source: Fundamental Pharma GmbH

FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director

PRESS RELEASE FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director Appointment underscores FundaMental’s ambition to develop medicines for neurodegenerative...
07 févr. 2024 08h00 HE | Source: Fundamental Pharma GmbH

FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis

PRESS RELEASE FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic...